A Personal Letter to All mdiConsultants, Inc. Clients
Unfortunately, I must announce the passing of Dr. Anand Akerkar (DR. A), President of mdi Consultants, Inc. Dr. A’s health has been failing in recent months and finally passed on.
Dr. A had been with mdi Consultants, Inc. since 1986 and had a very long and successful partnership with me. Anand came to mdi bringing a wealth of knowledge of the medical industry, government operations and business acumen.
He loved working with start-up companies and imparting his knowledge and experience to young entrepreneurs. His knowledge in the IVD industry was unmatched and he had a very keen insight into how the FDA worked. He loved traveling and had a chance to travel worldwide meeting with clients.
Dr. A was a very accomplished scientist. Dr, Akerkar will be missed by his co-workers, his family, and by myself, who has been his friend and his partner these past thirty-eight years.
May he rest in peace.
Alan P. Schwartz.
January 5, 2024
mdi Consultants Inc., with 45 years of experience in FDA regulatory compliance to the medical device, pharmaceutical, and food industries, is a leading provider of regulatory compliance consulting, FDA consulting for quality assurance, as well as International medical device compliance, and clinical services to the healthcare industry.
mdi Consultants’ services are focused on assisting medical device companies, pharmaceutical manufactures, and food industry companies across the globe to help them achieve regulatory and standards compliance.
mdi Consultants takes pride on keeping up-to-date on all aspects of the international healthcare industry; and, in some cases, ahead of the industry. Our News and Information section, our Insights Reports, our FDA Updates, and our newsletter are no different.
mdi Consultants provide up to the minute E.U. and FDA consulting services, tailored to the medical device industy, IVDD, pharmaceutical manufacturers and companies, and the food, nutrition and nutritional supplement industries.
It Is That Time of the Year Again…
The annual establishment registration renewal and drug listing certification period is now open and will close on December 31, 2023. This does not apply to private label distributors. You may submit a Blanket No Changes Certification of Product Listing if you are acting as an authorized agent for the registered establishment. (Please note: mdi has been providing this service for many of our clients. For Domestic companies their Off. Corresp. and foreign companies their US Agent and Official Correspondent.)
To keep establishment registration status current in 2024, FDA must receive notification that a firm’s registration information:
Being involved with all aspects of FDA compliance, for close to a half-century, we have speculated on when the Congress was going to give the FDA the authority to regulate the cosmetic industry. Recently, the FDA has recieved full autority to regulate the cosmetic industry as the FDA regulates the food, drug and medical device industries.
It is estimated that the new FDA Guidance for Cosmetic Manufacturers, and Distributors, will go into effect beginning December 2023.
The FDA Cosmetic guidance covers many areas of the cosmetic manufacturing and distribution, and should be looked at closely. The FDA provides guidance to the cosmetic industry, and other stakeholders, as to what constitutes Good Manufacturing Practices (GMP’s) for cosmetics. Also, this guidance revises the previously available “Cosmetic Good Manufacturing (GMP) Guidelines / Inspection Checklist” with new updates and clarifications based on recent FDA experience.
All foreign establishments of medical devices, human and animal drugs, and biologicals who manufacturer any of these products must have a designated agent in the USA:
medical device manufacturers, human and animal drug manufacturers, biological manufacturers.
Our FDA compliance service line will get your products to market quickly and to maintain your FDA compliance status. mdi has helped hundreds of companies to achieve and maintain their FDA compliance.
mdi Consultants provides Health Canada Regulatory consulting services as it has extensive experience with various regulatory submissions to Health Canada and can assist with bringing your products to Canadian market: Medical Device Classification, Medical Device Licensing for class II, III and IV, and more.
mdi Consultants can guide you to determine what is the best way to achieve a CE Mark and assist you through the entire process of securing it. We have helped over 100 companies successfully achieve the CE Mark. Our customer testimonials will provide you a glimpse of the experience of working with mdi on CE Marking.
Dietary supplements present a great opportunity for marketing and sale on the U.S. market. FDA’s regulatory system for manufacturing, labeling, manufacturing facility registration and product distribution is well defined and includes some of the most stringent requirements.
However, do not let the complexities of FDA regulations deter you from entering the dietary supplements market. mdi Consultants is well prepared to assist you with all phases of dietary supplements compliance.
FDA update We like to keep you abreast of various regulatory matters Read More...Posted on November 11, 2023
FDA Update It Is That Time of the Year Again… FDA Annual Read More...Posted on October 4, 2023
Over 200 years of cumulative industry experience on staff
Helped over 500 companies achieve FDA compliance and/ or ISO certification
Successfully prepared and submitted over a 1800 510(k) applications
Earned a 100% success rate in first time ISO certification
Successfully assisted obtaining CE mark for over 1000 products
Successfully assisted obtaining CE mark for over 1000 products
We want to express our appreciation for MDI’s guidance and assistance in helping us achieve our MDSAP (Medical Device Single Audit Program) certification. At this time, the MDSAP process is very new to both the companies wishing to obtain certification and the auditors. Success is only possible with in-depth understanding of all MDSAP requirements and their complete implementation.
The MDI Consultant team worked closely with our staff throughout the entire process providing stable and consistent support. Though there were several unexpected obstacles along the way, you continued to work and support the FEI staff to achieve its goal.
MDI’s professional and timely commitment to helping us achieve the MDSAP certification goal is exemplary. We hope to continue to work with MDI to support the compliant operations of our quality system as well as for other future projects.
Fabrication Enterprises Inc.
Dear Alan and mdi Consultants Team,
I am writing this letter to thank you for your outstanding work on assisting us with the quality system. Your expertise and attention to detail were tremendously valuable to our team.
mdi’s knowledgeable guidance of FDA regulations and constant support has contributed to our successful implementation of the quality system. Your insights and advice has been vital and sharp towards helping us complete the FDA inspection.
Looking forward the opportunity to working with you again.
Carilex Medical, Inc.
We want to thank mdi for your assistance with the most recent FDA inspection of our facilities in Taiwan.
Your guidance and composed demeanor throughout the inspection demonstrated your extensive experience and expertise in navigating FDA inspections and working with FDA investigators.
The inspection results were outstanding, and we cannot imagine going through future FDA inspections without the support of mdi. We strongly recommend mdi to any organization seeking assistance with the FDA.
Once again, we express our gratitude for your exceptional expertise and experience in ensuring the success of the inspection.
Merits Health Products Co., Ltd.
Taichung City, Taiwan